ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. – Regeneron Pharmaceuticals, Inc. Transaction History
ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. portfolio value:
$71.26M
portfolio value
ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +25.00% | 20.69K shares | 22.34M | $688.87 | 103.45K |
| Q2 2022 | share | Increase | +22.11% | 14.98K shares | 1.58M | $591.13 | 82.76K |
| Q1 2022 | share | Increase | +34.36% | 17.33K shares | 15.47M | $698.42 | 67.77K |
| Q4 2021 | share | Decrease | -13.97% | -8.19K shares | -3.63M | $642.51 | 50.44K |
| Q3 2021 | share | Increase | +57.44% | 21.39K shares | 14.68M | $605.18 | 58.63K |
| Q2 2021 | share | Decrease | -66.93% | -75.37K shares | -32.47M | $558.54 | 37.24K |
| Q1 2021 | share | Decrease | -28.94% | -45.85K shares | -23.27M | $473.14 | 112.61K |
| Q4 2020 | share | Decrease | -9.01% | -15.69K shares | -20.93M | $483.11 | 158.47K |
| Q3 2020 | share | Increase | +12.28% | 19.05K shares | 753K | $559.78 | 174.17K |
| Q2 2020 | share | Increase | +338.64% | 119.75K shares | 79.47M | $623.65 | 155.12K |
| Q1 2020 | share | Increase | +170.49% | 22.29K shares | 12.36M | $488.29 | 35.36K |
| Q4 2019 | share | Decrease | -28.15% | -5.12K shares | -139K | $375.48 | 13.07K |
| Q3 2019 | share | Decrease | -5.94% | -1.15K shares | -1.00M | $277.4 | 18.19K |
| Q2 2019 | share | Decrease | -9.18% | -1.95K shares | -2.69M | $313 | 19.34K |
| Q1 2019 | share | Increase | +59.32% | 7.93K shares | 3.76M | $410.62 | 21.30K |
| Q4 2018 | share | Increase | +140.29% | 7.80K shares | 2.73M | $373.5 | 13.37K |
| Q3 2018 | share | Increase | +21.91% | 1K shares | 672K | $404.04 | 5.56K |
| Q2 2018 | share | Decrease | -12.93% | -678 shares | -231K | $344.99 | 4.56K |
| Q1 2018 | share | Increase | +405.01% | 4.20K shares | 1.41M | $344.36 | 5.24K |
| Q4 2017 | share | 0.00% | 0 shares | -72K | $375.96 | 1.03K | |
| Q3 2017 | share | Increase | +1.17% | 12 shares | -41K | $447.12 | 1.03K |
| Q2 2017 | share | 0.00% | 0 shares | 106K | $491.14 | 1.02K | |
| Q1 2017 | share | Decrease | -5.09% | -55 shares | 2K | $387.51 | 1.02K |
| Q4 2016 | share | Decrease | -68.05% | -2.30K shares | -964K | $367.09 | 1.08K |
| Q3 2016 | share | Decrease | -38.92% | -2.15K shares | -574K | $402.02 | 3.38K |
| Q2 2016 | share | 0.00% | 0 shares | -62K | $349.23 | 5.53K | |
| Q1 2016 | share | Decrease | -18.56% | -1.26K shares | -1.69M | $360.44 | 5.53K |